What is the address of JYMEDICAL?

The registered office of JYMEDICAL is located at Paepestraat 64, 9260 Wichelen.

Is JYMEDICAL still active?

Yes. According to the CBE (31 October 2026) JYMEDICAL is active, legal situation “Normale toestand”, started on 21 May 2021.

Is JYMEDICAL registered on Peppol?

Yes, JYMEDICAL is registered on the Peppol network with ID 0208:0768650071.

What is the enterprise number of JYMEDICAL?

The enterprise number of JYMEDICAL is BE0768650071.

When was JYMEDICAL founded?

JYMEDICAL was founded on 21 May 2021.

Who are the directors of JYMEDICAL?

According to the 2025 annual accounts, the directors of JYMEDICAL are: Jonas Yserbyt.

Is JYMEDICAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 May 2021; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did JYMEDICAL make in 2025?

JYMEDICAL posted a profit after taxes of € 359,230 in financial year 2025.

What is the revenue of JYMEDICAL?

As a small company, JYMEDICAL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 492,052.

Does JYMEDICAL have a website?

Yes, JYMEDICAL has a website at apotheekvanschepdael.be.

JYMEDICAL (Private Limited) - Wichelen - BE0768650071

Dossier JYMEDICAL, printed on 1 November 2026 from databakkes.be/en/0768650071/jymedical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

JYMEDICAL from Wichelen, company number BE0768650071, closed financial year 2025 with a result of € 359,230 after tax. For that financial year JYMEDICAL recorded a gross margin of € 492,052 and equity of € 2,000. Compared with financial year 2024, the result moved from € 311,763 to € 359,230. Profitable, and profit is growing. The buffer shrank hard: equity is 100 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 7, 2026.

What it is worth Shrank hard

€ 2,000

▼ € 858,487 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 359,230

▲ 15% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 100,535

▼ 66% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 1.2 million paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 35,625

▼ 34% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2,833

▲ 161% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 55,127

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 412,657 Gross margin 2022: € 412,657 First fiscal year in the series	€ 326,436 Gross margin 2023: € 326,436 ▼ 21% vs 2022 (€ 412,657) Unfavourable step	€ 431,086 Gross margin 2024: € 431,086 ▲ 32% vs 2023 (€ 326,436) Favourable step	€ 492,052 Gross margin 2025: € 492,052 ▲ 14% vs 2024 (€ 431,086) Favourable step	▲ 14%
Profit after taxes	€ 313,373 Profit after taxes 2022: € 313,373 First fiscal year in the series	€ 233,351 Profit after taxes 2023: € 233,351 ▼ 26% vs 2022 (€ 313,373) Unfavourable step	€ 311,763 Profit after taxes 2024: € 311,763 ▲ 34% vs 2023 (€ 233,351) Favourable step	€ 359,230 Profit after taxes 2025: € 359,230 ▲ 15% vs 2024 (€ 311,763) Favourable step	▲ 15%
Equity	€ 315,373 Equity 2022: € 315,373 First fiscal year in the series	€ 548,724 Equity 2023: € 548,724 ▲ 74% vs 2022 (€ 315,373) Favourable step	€ 860,487 Equity 2024: € 860,487 ▲ 57% vs 2023 (€ 548,724) Favourable step	€ 2,000 Equity 2025: € 2,000 ▼ € 858,487 vs 2024 (€ 860,487) Unfavourable step	▼ € 858,487
Total debts	€ 72,882 Total debts 2022: € 72,882 First fiscal year in the series	€ 12,845 Total debts 2023: € 12,845 ▼ 82% vs 2022 (€ 72,882) Favourable step	€ 1,086 Total debts 2024: € 1,086 ▼ 92% vs 2023 (€ 12,845) Favourable step	€ 365,972 Total debts 2025: € 365,972 ▲ € 364,886 vs 2024 (€ 1,086) Unfavourable step	▲ € 364,886
Cash	€ 174,869 Cash 2022: € 174,869 First fiscal year in the series	€ 344,799 Cash 2023: € 344,799 ▲ 97% vs 2022 (€ 174,869) Favourable step	€ 295,141 Cash 2024: € 295,141 ▼ 14% vs 2023 (€ 344,799) Unfavourable step	€ 100,535 Cash 2025: € 100,535 ▼ 66% vs 2024 (€ 295,141) Unfavourable step	▼ 66%
Land & buildings	-	€ 6,460 Land & buildings 2023: € 6,460 First fiscal year in the series	€ 4,906 Land & buildings 2024: € 4,906 ▼ 24% vs 2023 (€ 6,460) Unchanged	€ 3,353 Land & buildings 2025: € 3,353 ▼ 32% vs 2024 (€ 4,906) Unchanged	▼ 32%
Retained profit	€ 313,373 Retained profit 2022: € 313,373 First fiscal year in the series	€ 546,724 Retained profit 2023: € 546,724 ▲ 74% vs 2022 (€ 313,373) Favourable step	€ 858,487 Retained profit 2024: € 858,487 ▲ 57% vs 2023 (€ 546,724) Favourable step	€ 0 Retained profit 2025: € 0 ▼ 100% vs 2024 (€ 858,487) Unfavourable step	▼ 100%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 1,217,717 Dividend 2025: € 1,217,717 Unchanged (€ 0) Unchanged
Balance sheet total	€ 388,256 Balance sheet total 2022: € 388,256 First fiscal year in the series	€ 561,569 Balance sheet total 2023: € 561,569 ▲ 45% vs 2022 (€ 388,256) Unchanged	€ 861,573 Balance sheet total 2024: € 861,573 ▲ 53% vs 2023 (€ 561,569) Unchanged	€ 367,972 Balance sheet total 2025: € 367,972 ▼ 57% vs 2024 (€ 861,573) Unchanged	▼ 57%

Key figures of JYMEDICAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to JYMEDICAL?

What happened at JYMEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 7, 2026 New annual accounts for financial year 2025: profit of € 359,230 (▲ 15% vs 2024). Source: NBB ↗
May 21, 2021 New establishment in Wichelen. KBO
May 21, 2021 Start of the company according to the CBE. KBO

In short

From € 313,373 profit in 2022 to € 359,230 profit in 2025.

Paid € 380,180 in corporate taxes since 2022.

Best year ever: 2025, with € 359,230 profit.

Paid out € 1.2 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Jonas Yserbyt

JYMEDICAL

Behind JYMEDICAL is Jonas Yserbyt.

Directors

According to the 2025 annual accounts

Jonas Yserbyt

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Paepestraat 64

9260 Wichelen

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

APOLEX

€ 118,353 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS apotheekvanschepdael.be

Technologies

Alpine.jsApacheBunny CDNFont AwesomeGoogle FontsreCAPTCHA

Hosting & Email

Email provider

Microsoft 365

Hosting

AMAZON-02 - Amazon.com, Inc., US

DNS

AWS Route 53

Website info

HTTPS Ja

Languages NL

Features

Webshop Client portal Contact page

Security

✓ HTTPS

✓ SPF

✗ DMARC

Network

✓ IPv6

✓ Load balancing

Details

Company number: 0768.650.071
VAT number: BE 0768.650.071
Registered office: Paepestraat 64, 9260 Wichelen
Names & denominations: JYMEDICAL
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 21 May 2021
Peppol: Active · Active since 2 Sept 2025
Contact: apotheekvanschepdael.be

View on CBE Public ↗ Annual accounts (NBB) ↗